Dr. Shadi Farhangrazi
Co-Founder and Chief Executive Officer
Dr. Shadi Farhangrazi, PhD., MS., MBA is a biochemist, neuroscientist, infectious diseases expert, and an expert in the area of future and emerging technologies, innovation and entrepreneurship. She formerly was the founder of management consulting firm Biotrends International. Dr. Farhangrazi is also a faculty at University College, University of Denver, teaching classes on entrepreneurship, innovation, strategy and non-profit management. In 2015, Dr. Farhangrazi was a Visiting Guest Professor at Università Degli Studi Di Padova (Italy).
Internationally recognized speaker, Dr. Farhangrazi teaches and works globally, and is an advisor and consultant to major multinational companies, governmental and non-governmental organizations and biotechnology companies in such diverse areas as strategy and business development, product placement and introduction, international development as well as global health. Dr. Farhangrazi has worked on multi million dollars to multi billion dollars projects with multinational companies and organizations including Boeing Co., The US State Department, USAID, The Home Depot Foundation, ALS Foundation and over 45 companies (small and early stage enterprises to companies which are now publicly traded) and organizations worldwide. Dr. Farhangrazi has advised numerous companies globally and her work has taken her over the last decade from back-country remote town and villages in Rwanda, slums of Kenya and Mumbai, Research Parks in India and Malaysia, high tech companies in Silicon Valley, US and Europe to working with international companies and organizations and meetings with global leaders.
For her graduate work, she characterized a family of Peroxidases (proteins); for the first time named them "Acid Peroxidases" and characterized several enzymatic proteins for the first time. As a neuroscientist, she published one of the first works demonstrating the role of good cholesterol (HDL) in Alzheimer's disease and on lowering the toxicity of Beta-Amyloid in assays. Dr. Farhangrazi has written numerous scientific papers, articles, commentaries, reviews, book chapters and frequently speaks nationally and internationally on science and business topics including science education, neurological diseases, innovation, entrepreneurship and biotechnology industry.
Dr. Farhangrazi has given hundreds of talks and teaches classes and workshops nationally and across the world including workshops on biotechnology leadership and management at universities across Europe. She has been interviewed and profiled by many media outlets including the National Public Radio (NPR), St. Louis Post Dispatch, American Medical News, Nature, the Daily Beast, the Denver Post, and several other American news outlets and radio and television stations.
Dr. Farhangrazi was formerly, the Executive Director and Chief Executive Officer of the National Center for the Study of Orphan Diseases (CSOD), Research Assistant Professor of Neurology and Neurological Surgery, faculty in the Center for the Study of Nervous System Injury, and the Science and Business Liaison for the Spinal Cord Injury Research and Rehabilitation Program, at Washington University School of Medicine, Department of Neurology and Neurosurgery in St. Louis, Missouri. Dr. Farhangrazi holds a Bachelors degree in Chemistry and mathematics from Weber State University, a Masters degree in Biochemistry with focus in Immunology, and a PhD in Biochemistry with focus in Protein Design and engineering from the National Center for Design of Molecular Function, Utah State University, and an MBA from the Merage College of Business, University of California, Irvine. She completed postdoctoral fellowships and research training in neurosciences at Washington University School of Medicine, St. Louis, and University of California, Irvine.
Chief Operations Officer
As a 35-year professional in marketing and organizational operations, Bryan has built four enterprises serving national and global brands and their related companies.
As the founder and CEO of Thomas & Perkins, a national marketing agency, Bryan grew the organization to 120 employees with annual billings of nearly $90 million. The company was instrumental in growing customers and market share for organizations within the health care sector including National Jewish Health, the leading US respiratory treatment and research center for pulmonary, cardiac, immune and related conditions, Air Methods Corporation, the worlds largest air medical transport company, UW Medicine, a renown medical and research center in the US northeast, Direct Patient Logistics, the leading patient transfer facilitation provider in the US, TeleMethods, a telemedicine incubator for Air Methods and Psychiatric Institutes of America, Rose Medical Center, Centura Health, and CIGNA Select. The agency gained a reputation for strategically guiding brand positioning, value proposition development, consumer insight studies, marketing strategy, marketing communications plans and their execution. It was recognized as one of the more inventive ad agencies in the US.
Other companies Bryan has founded, built and sold include Thomas Taber & Drazen (TTD), a strategic marketing outsource provider for companies seeking marketing muscle for their growth objectives. TTD eventually grew to $35 million in annual billings and was sold by Bryan to Gyro, a global marketing agency.
Bryan also co-founded Saligent, a sales-force support, outbound, lead-generation company that grew to 150 staff members at the time it was sold to Protocol Communications.
Bryan has served on board of directors or advisory councils for Rocky Mountain Children’s Law Center, Mile High United Way and the Children’s Museum. However, his greatest accomplishment (with a lot of help from his wife) is his five children and 8 grandchildren.
Senior Vice-President for Corporate Development
Gary Leo is a seasoned senior management professional with a proven track-record in institutional development for major philanthropic organizations in education, healthcare and social services. Leo brings broad experience in successful implementation of development strategies, board and staff training, and noteworthy organizational advancement in the health sector.
Over the years, Leo has created and implemented novel strategic plans that raised over $500 million, personally managed and administered hundreds of organizational development and communications professionals, program planners and executive personnel in directing comprehensive programs and services for major national and international health, welfare and educational institutions.
A nationally recognized management and development executive, Leo most recently served as president and chief executive officer of The ALS Association, the nation’s preeminent organization in the fight against Lou Gehrig’s disease. Prior to joining The ALS Association, Leo was senior vice president for development at Cedars-Sinai Medical Center in Los Angeles, the largest non-profit acute care academic medical center in the western United States. Prior to his work at Cedars-Sinai, Leo served as national vice president director and executive director of the Western Region of the American Society for Technion – Israel Institute of Technology, Israel’s oldest university and primary educator of engineers, scientists and medical professionals.
Leo holds a master’s degree in social work administration from Rutgers University in New Jersey, a master’s degree in educational administration from New York University and a bachelor’s degree in economics from Queens College in New York.
Senior Vice-President, Legal Counsel
Geoff Lewis has a distinguished 30-year career in law and business. He has over a billion dollars of transactional experience in securities, IPOs, mergers & acquisitions, corporate finance, joint ventures and contracts with one of the largest corporate law firms in the world and with three NYSE-listed companies.
Geoff was most recently President of RE/MAX International Holdings, an international franchise and marketing company with a presence in over 100 countries. Geoff was instrumental in taking RE/MAX public on the NYSE in 2013. Prior to serving as President, Geoff was Chief Legal Officer.
Prior to that, Geoff was Vice President Corporate Development and General Counsel of Hyster-Yale Materials Handling, Inc., a market leading global manufacturing company ($2 billion) (NYSE: HY). He led the Corporate Development group overseeing acquisitions, dispositions and joint ventures on five continents. He managed corporate finance and legal and regulatory compliance for 17 worldwide locations. Geoff was responsible for a $65 million budget.
Geoff has also served as Vice President, General Counsel of American Health Properties, Inc., a NYSE-listed real estate investment trust that owned acute-care hospitals. He was responsible for securities offerings, corporate finance and acquisitions.
He also practiced corporate and securities law in the Los Angeles office of the international corporate law firm Jones Day with over 1,000 attorneys in offices worldwide.
Geoff is Chairman of the Board of Volunteers of America, Colorado Branch, a non-profit organization serving the homeless, seniors, children, women and veterans.
He received a law degree from the University of Virginia, an MBA from the University of Colorado and a B.A. from Brigham Young University.